Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Everolimus
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum Zuid
P2/3
B
(57)
Exv-801
Alzheimer Disease
Exciva GmbH
P2/3
B
(57)
Exv-802
Alzheimer Disease
Exciva GmbH
P2/3
B
(57)
Fampridine
Traumatic Neuropathy
John Elfar
P2/3
B
(57)
FILGRASTIM
Rare
Hospices Civils de Lyon
P2/3
B
(57)
GEH300079 (68Ga)
Gastric Cancer
GE Healthcare
P2/3
B
(57)
GEH300079 (68Ga)
Ovarian Cancer
GE Healthcare
P2/3
B
(57)
Ginkgo Diterpene Lactone Meglumine
Ischemic Stroke
Ying Gao
P2/3
B
(57)
Gnrh
Cognitive Disorder
Nelly Pitteloud
P2/3
B
(57)
Gnrh
Down Syndrome
Nelly Pitteloud
P2/3
B
(57)
Gnrh
Olfactory Nerve Disorder
Nelly Pitteloud
P2/3
B
(57)
Gonadotropin-Releasing Hormone
Cognitive Disorder
Nelly Pitteloud
P2/3
B
(57)
Gonadotropin-Releasing Hormone
Down Syndrome
Nelly Pitteloud
P2/3
B
(57)
Gonadotropin-Releasing Hormone
Olfactory Nerve Disorder
Nelly Pitteloud
P2/3
B
(57)
Grt-C901
Colorectal Neoplasm
Gritstone bio, Inc.
P2/3
B
(57)
Grt-R902
Colorectal Neoplasm
Gritstone bio, Inc.
P2/3
B
(57)
Haloperidol
Delirium
Benha University
P2/3
B
(57)
Haloperidol
Epilepsy
M.D. Anderson Cancer Center
P2/3
B
(57)
hb1801
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.
P2/3
B
(57)
hlx22
HER2 Positive Breast Carcinoma
Shanghai Henlius Biotech
P2/3
B
(57)
hlx43
Non-Small Cell Squamous Lung Carcinoma
Shanghai Henlius Biotech
P2/3
B
(57)
HLX87
HER2 Positive Breast Carcinoma
Shanghai Henlius Biotech
P2/3
B
(57)
HUMAN IMMUNOGLOBULINS
Hematopoietic And Lymphoid System Neoplasm
Monash University
P2/3
B
(57)
HUMAN IMMUNOGLOBULINS
Syndromic Agammaglobulinemia
Monash University
P2/3
B
(57)
HUMAN IMMUNOGLOBULINS
Non-Hodgkin Lymphoma
Monash University
P2/3
B
(57)
Showing 526 to 550 of 1,055 assets
Previous
Page 22 of 43
Next